Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-OX40L (Clone R4930 (Oxelumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
Applications | ELISA, IHC |
Reactivities | Human |
Recombinant Anti-Fas (Clone R-125224)
Applications | ELISA, FC |
Reactivities | Human |
Anti-TIGIT [AET2010], Human IgG1, lambda
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
Applications | FC |
Reactivities | Human, Monkey |
Recombinant Anti-CD80 (Clone 16C10)
Applications | ELISA |
Reactivities | Human |
Recombinant Anti-Bet v 1 (Clone M0418)
Applications | ELISA |
Recombinant Anti-Rhesus D antigen (Clone D7C2)
Applications | FC |
Reactivities | Human |
Recombinant Anti-desmosome/hemidesmosome (Clone F12)
Applications | IF |
Reactivities | Human |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
Applications | ELISA |
Reactivities | Human |
Anti-CD3 [CD3B219], Human IgG4, lambda
Applications | FC |
Reactivities | Human, Monkey |
Anti-Cytokeratin 18 [HH156], Human IgG1, kappa
Applications | ELISA |
Reactivities | Human |
CNY 6,881.00
6周
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
CNY 6,881.00
6周
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)